Circulating Adiponectin and Its Association with Metabolic Traits and Type 2 Diabetes: Gene-Diet Interactions Focusing on Selected Gene Variants and at the Genome-Wide Level in High-Cardiovascular Risk Mediterranean Subjects.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Feb 2021
Historique:
received: 20 12 2020
revised: 26 01 2021
accepted: 02 02 2021
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 8 9 2021
Statut: epublish

Résumé

Adiponectin is gaining renewed interest since, in addition to its possible protective role against insulin resistance and arteriosclerosis, recent studies suggest other additional favorable effects. However, the influence of gene-diet interactions on plasma adiponectin levels is still little understood. We analyzed the association between plasma adiponectin levels and various metabolic traits in a high-cardiovascular risk Mediterranean population, as well as the genetic effect of four candidate single-nucleotide polymorphisms (SNPs) in the adiponectin gene (

Identifiants

pubmed: 33562295
pii: nu13020541
doi: 10.3390/nu13020541
pmc: PMC7914877
pii:
doi:

Substances chimiques

Adiponectin 0
VAT1 protein, human 0
Vesicular Transport Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Generalitat Valenciana
ID : PROMETEO 17/2017
Organisme : Fundació La Marató de TV3
ID : 538/U/2016
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : CIBER 06/03
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI06/1326
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI13/00728
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI16/00366
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : PI19/00781
Organisme : Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER)
ID : SAF2016-80532-R
Organisme : University Jaume I
ID : P1-1B2013-54 and COGRUP/2016/06
Organisme : The Rei Jaume I Award for Medical Research 2018
ID : Medical Research 2018
Organisme : Generalitat Valenciana
ID : APOSTD/2019/136

Références

PLoS One. 2012;7(12):e52344
pubmed: 23284998
Biochimie. 2012 Oct;94(10):2157-63
pubmed: 22449616
Cardiovasc Diabetol. 2020 Aug 8;19(1):125
pubmed: 32771014
J Hum Genet. 2008;53(8):718-727
pubmed: 18523726
PLoS Genet. 2009 Dec;5(12):e1000768
pubmed: 20011104
J Biol Chem. 1996 May 3;271(18):10697-703
pubmed: 8631877
Bioinformatics. 2015 Apr 15;31(8):1334-6
pubmed: 25431330
Int J Prev Med. 2018 Dec 05;9:106
pubmed: 30622689
Eur J Pharmacol. 2002 Apr 12;440(2-3):213-21
pubmed: 12007537
Diabetes Care. 2006 Nov;29(11):2498-503
pubmed: 17065691
JAMA. 2004 Apr 14;291(14):1730-7
pubmed: 15082700
BMC Genomics. 2019 Dec 5;20(1):934
pubmed: 31805863
Nat Metab. 2019 Mar;1(3):334-339
pubmed: 32661510
Int J Mol Sci. 2019 Mar 08;20(5):
pubmed: 30857216
Eur J Endocrinol. 2009 Dec;161(6):845-52
pubmed: 19755407
Hum Mutat. 2012 Feb;33(2):402-10
pubmed: 22065538
PLoS One. 2020 Oct 22;15(10):e0241078
pubmed: 33091065
Sci Rep. 2018 Jan 10;8(1):406
pubmed: 29321603
BMC Proc. 2009 Dec 15;3 Suppl 7:S41
pubmed: 20018033
Sci Rep. 2020 Feb 19;10(1):2904
pubmed: 32076038
Endocrine. 2017 Dec;58(3):542-552
pubmed: 29039145
PLoS Genet. 2020 Sep 11;16(9):e1009019
pubmed: 32915782
Nat Commun. 2019 Jul 19;10(1):3222
pubmed: 31324783
Endocr Metab Immune Disord Drug Targets. 2015;15(2):145-50
pubmed: 25772181
Hum Mol Genet. 2010 Dec 15;19(24):4955-64
pubmed: 20876611
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Horm Metab Res. 2020 Oct;52(10):695-707
pubmed: 32927496
Vasc Health Risk Manag. 2015 Jan 16;11:55-70
pubmed: 25653535
Diabetologia. 2011 May;54(5):1019-24
pubmed: 21336532
Molecules. 2020 Nov 09;25(21):
pubmed: 33182462
Am J Clin Nutr. 2019 Jun 1;109(6):1709-1723
pubmed: 31005965
J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72
pubmed: 18492747
Am J Hum Genet. 2010 Oct 8;87(4):545-52
pubmed: 20887962
Cardiovasc Diabetol. 2012 Nov 06;11:137
pubmed: 23130628
Diabetes. 2011 Sep;60(9):2417-23
pubmed: 21771975
Int Angiol. 2014 Oct;33(5):434-40
pubmed: 25294284
J Intern Med. 2005 Feb;257(2):167-75
pubmed: 15656875
BMC Med Genet. 2009 May 09;10:39
pubmed: 19426517
Genome Biol. 2018 Nov 14;19(1):179
pubmed: 30424772
PLoS One. 2011 Apr 04;6(4):e18182
pubmed: 21483749
Diabetes Care. 2011 Jan;34(1):14-9
pubmed: 20929998
Am J Cardiol. 2016 Feb 15;117(4):574-579
pubmed: 26800774
PLoS One. 2015 Jul 20;10(7):e0133404
pubmed: 26193471
JAMA. 2009 Jul 8;302(2):179-88
pubmed: 19584347
PLoS Genet. 2012;8(3):e1002607
pubmed: 22479202
Int J Prev Med. 2020 Sep 03;11:136
pubmed: 33088464
J Nutr. 2019 Apr 1;149(4):676-686
pubmed: 30927000
J Nutr. 2011 Jun;141(6):1140-5
pubmed: 21508208
Nat Genet. 2019 Apr;51(4):584-591
pubmed: 30926966
Crit Care. 2011 Apr 20;15(2):221
pubmed: 21586104
Am J Clin Nutr. 2008 Nov;88(5):1213-24
pubmed: 18996855
J Res Med Sci. 2015 Feb;20(2):178-84
pubmed: 25983773
Endocr Metab Immune Disord Drug Targets. 2020;20(4):506-517
pubmed: 31368881
Eur J Nutr. 2009 Dec;48(8):493-7
pubmed: 19543786
Proc Nutr Soc. 2012 Feb;71(1):141-53
pubmed: 22040870
J Endocrinol. 2010 Jun;205(3):243-52
pubmed: 20338998
Diabetes. 2013 Dec;62(12):4277-83
pubmed: 24009259
Mol Endocrinol. 2012 Jan;26(1):79-86
pubmed: 22053002
Nutr Metab Cardiovasc Dis. 2020 Jun 9;30(6):872-888
pubmed: 32409275
Microvasc Res. 2021 Mar;134:104123
pubmed: 33333140
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):29-33
pubmed: 14551151
Am J Clin Nutr. 2006 Aug;84(2):328-35
pubmed: 16895879
J Nutr. 2013 Jul;143(7):1021-7
pubmed: 23658423
J Biol Chem. 1995 Nov 10;270(45):26746-9
pubmed: 7592907
Diabetes Care. 2007 May;30(5):1200-5
pubmed: 17322479
Int J Obes (Lond). 2007 Mar;31(3):535-42
pubmed: 16894363
Circulation. 1999 Dec 21-28;100(25):2473-6
pubmed: 10604883
Cardiovasc Res. 2009 Jan 1;81(1):98-107
pubmed: 18815186
Atherosclerosis. 2010 Feb;208(2):412-20
pubmed: 20018283
FEBS Lett. 2006 May 22;580(12):2917-21
pubmed: 16674947
Int J Mol Sci. 2020 Feb 12;21(4):
pubmed: 32059381
Diabetes. 2008 Dec;57(12):3353-9
pubmed: 18776141
Hum Mol Genet. 2014 Feb 15;23(4):1108-19
pubmed: 24105470
Oncotarget. 2017 Aug 24;8(42):72847-72859
pubmed: 29069830
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):987-94
pubmed: 23149075
Cereb Cortex. 2019 Feb 1;29(2):838-851
pubmed: 30535007
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
J Clin Endocrinol Metab. 2001 Sep;86(9):4321-5
pubmed: 11549668
Am J Ther. 2017 May;24(3):e308-e316
pubmed: 26760913
Biochimie. 2012 Oct;94(10):2137-42
pubmed: 22713764
Nutrients. 2019 Jan 04;11(1):
pubmed: 30621171
Endocrinol Diabetes Nutr. 2019 Jan;66(1):49-55
pubmed: 30266593
Nutrition. 2019 Sep;65:44-49
pubmed: 31029921
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Annu Rev Food Sci Technol. 2018 Mar 25;9:227-249
pubmed: 29400994
Nutrients. 2019 Nov 13;11(11):
pubmed: 31766143
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Nutrients. 2020 Jan 24;12(2):
pubmed: 31991592
Expert Rev Mol Med. 2006 Nov 20;8(27):1-12
pubmed: 17112391
J Thorac Dis. 2019 Dec;11(12):5417-5426
pubmed: 32030260
Eur J Hum Genet. 2006 Mar;14(3):349-56
pubmed: 16418740
Sci Rep. 2020 Dec 10;10(1):21736
pubmed: 33303765
Atherosclerosis. 2013 May;228(1):29-35
pubmed: 23489345
Am J Med Sci. 2013 Jun;345(6):455-61
pubmed: 23123561
Obes Rev. 2007 Sep;8(5):419-23
pubmed: 17716299

Auteurs

Oscar Coltell (O)

Department of Computer Languages and Systems, Universitat Jaume I, 12071 Castellón, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Carolina Ortega-Azorín (C)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Jose V Sorlí (JV)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Olga Portolés (O)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Eva M Asensio (EM)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Carmen Saiz (C)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Rocío Barragán (R)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Sleep Center of Excellence, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.
Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.

Ramon Estruch (R)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Internal Medicine, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.

Dolores Corella (D)

CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH